Ncardia

Ncardia

Biotechnologisch onderzoek

Leiden, South Holland 15.181 volgers

Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster.

Over ons

Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications. Explore our website to learn more www.ncardia.com.

Branche
Biotechnologisch onderzoek
Bedrijfsgrootte
51 - 200 medewerkers
Hoofdkantoor
Leiden, South Holland
Type
Particuliere onderneming
Opgericht
2011
Specialismen
stem cells, ipsc, cardiomyocytes, neurons, drug discovery, drug development, cardiovascular safety, cardiovascular efficacy, neural safety, neural efficacy, CRO, fibroblast, astrocytes, electrophysiology, safety pharmacology, toxicology, assay development, contraction assays, custom cell lines, assay solutions, disease modeling, HTS en CMO

Locaties

  • Primair

    Ncardia Leiden, Galileiweg 8

    Building BioPartner 1

    Leiden, South Holland 2333 BD , NL

    Routebeschrijving

Medewerkers van Ncardia

Updates

Vergelijkbare pagina’s

Door vacatures bladeren